menu
    • menu

    Company profile for Karuna Therapeutics

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Smithfield BioScience transforms bioproducts into trusted, life-saving therapies through safe, reliable U.S.-based manufacturing.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    SWATI - Transforming science into solutions with 60+ years of expertise, global accreditations, and pioneering biotech innovation.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Karuna is a clinical-stage biopharmaceutical company committed to developing and delivering first-in-class therapies with the potential to transform the lives of people with CNS disorders – which remain among the most disabling and potentially fatal disorders worldwide. Galvanized by the understanding that today’s neuropsychiatric patients deserve better, Karuna’s mission is to harness the untapped potential of the brain...
    Karuna is a clinical-stage biopharmaceutical company committed to developing and delivering first-in-class therapies with the potential to transform the lives of people with CNS disorders – which remain among the most disabling and potentially fatal disorders worldwide. Galvanized by the understanding that today’s neuropsychiatric patients deserve better, Karuna’s mission is to harness the untapped potential of the brain’s complex biology in pursuit of novel therapeutic pathways that will advance the standard of care.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Karuna TherapeuticsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    Karuna Therapeutics 33 Arch Street Suite 3110 Boston, MA 02110
    Telephone
    Telephone
    (857) 449-2244
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://karunatx.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/karuna-therapeutics/
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/KarunaPharma

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    DDL Conference

    Not Confirmed

    envelop Contact Supplier

    DDL Conference

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Karuna, Naurex Alumni Launch Biotech for Neuro Diseases
    Karuna, Naurex Alumni Launch Biotech for Neuro Diseases

    27 May 2025

    // BIOSPACE

    https://www.biospace.com/business/karuna-naurex-alumni-launch-new-biotech-to-modulate-synaptic-plasticity-for-neuro-diseases

    BIOSPACE
    27 May 2025
    Share Share
    Neurocrine's drug cuts schizophrenia symptoms in mid-stage study
    Neurocrine's drug cuts schizophrenia symptoms in mid-stage study

    29 Aug 2024

    // REUTERS

    https://www.reuters.com/business/healthcare-pharmaceuticals/neurocrines-schizophrenia-drug-meets-main-goal-mid-stage-study-2024-08-28/

    REUTERS
    29 Aug 2024
    Share Share
    Karuna's captains set sail in new neuropsychiatric biotech
    Karuna's captains set sail in new neuropsychiatric biotech

    09 Apr 2024

    // James Waldron FIERCE BIOTECH

    https://www.fiercebiotech.com/biotech/karunas-captains-set-sail-new-neuropsychiatric-venture-called-seaport-therapeutics

    James Waldron FIERCE BIOTECH
    09 Apr 2024
    Share Share
    BMS Completes Acquisition of PureTech's Founded Entity Karuna for $14 Billion
    BMS Completes Acquisition of PureTech's Founded Entity Karuna for $14 Billion

    18 Mar 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240318509649/en

    BUSINESSWIRE
    18 Mar 2024
    Share Share
    Karuna Therapeutics set to merge with Bristol-Myers Squibb
    Karuna Therapeutics set to merge with Bristol-Myers Squibb

    13 Mar 2024

    // PRESS RELEASE

    https://in.investing.com/news/karuna-therapeutics-set-to-merge-with-bristolmyers-squibb-93CH-4068675#:~:text=Upon%20completion%2C%20Karuna%20will%20operate,rheumatoid%20arthritis%2C%20and%20psychiatric%20disorders.

    PRESS RELEASE
    13 Mar 2024
    Share Share
    Karuna ‘vigorously’ denies wrongdoing in shareholder lawsuit
    Karuna ‘vigorously’ denies wrongdoing in shareholder lawsuit

    01 Mar 2024

    // Gabrielle Masson FIERCE BIOTECH

    https://www.fiercebiotech.com/biotech/response-shareholder-lawsuit-karuna-vigorously-denies-wrongdoing-and-provides-further-info

    Gabrielle Masson FIERCE BIOTECH
    01 Mar 2024
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search